Menu
GeneBe

KLHL41

kelch like family member 41, the group of Kelch like|BTB domain containing

Basic information

Region (hg38): 2:169509701-169526258

Previous symbols: [ "KBTBD10" ]

Links

ENSG00000239474NCBI:10324OMIM:607701HGNC:16905Uniprot:O60662AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • nemaline myopathy 9 (Strong), mode of inheritance: AR
  • severe congenital nemaline myopathy (Supportive), mode of inheritance: AR
  • intermediate nemaline myopathy (Supportive), mode of inheritance: AD
  • typical nemaline myopathy (Supportive), mode of inheritance: AD
  • childhood-onset nemaline myopathy (Supportive), mode of inheritance: AD
  • nemaline myopathy 9 (Moderate), mode of inheritance: AR
  • nemaline myopathy 9 (Moderate), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Nemaline myopathy 9ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal24268659

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the KLHL41 gene.

  • Nemaline myopathy 9 (230 variants)
  • not provided (52 variants)
  • Inborn genetic diseases (24 variants)
  • not specified (8 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the KLHL41 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
58
clinvar
1
clinvar
61
missense
1
clinvar
133
clinvar
8
clinvar
2
clinvar
144
nonsense
5
clinvar
1
clinvar
1
clinvar
7
start loss
0
frameshift
8
clinvar
4
clinvar
12
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
2
clinvar
2
splice region
1
4
2
7
non coding
23
clinvar
9
clinvar
32
Total 13 6 138 91 12

Highest pathogenic variant AF is 0.0000197

Variants in KLHL41

This is a list of pathogenic ClinVar variants found in the KLHL41 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-169509786-C-T not specified • Nemaline myopathy 9 Benign (Feb 01, 2024)259913
2-169509792-G-A Nemaline myopathy 9 Uncertain significance (Dec 09, 2021)1415101
2-169509793-G-A Nemaline myopathy 9 • KLHL41-related disorder Benign/Likely benign (Jan 10, 2024)474866
2-169509800-G-A Nemaline myopathy 9 Uncertain significance (Jan 21, 2020)1035863
2-169509801-C-T Inborn genetic diseases Uncertain significance (Dec 13, 2023)3115758
2-169509811-G-C Nemaline myopathy 9 Likely benign (Sep 13, 2023)3022643
2-169509828-C-G Nemaline myopathy 9 Uncertain significance (Jul 01, 2022)2185775
2-169509830-C-T Nemaline myopathy 9 Uncertain significance (Mar 22, 2022)2146844
2-169509839-G-C Nemaline myopathy 9 Uncertain significance (Mar 13, 2022)2069133
2-169509843-G-C Nemaline myopathy 9 Uncertain significance (Oct 18, 2022)1479763
2-169509851-G-A Nemaline myopathy 9 Uncertain significance (Mar 29, 2022)2116034
2-169509851-G-T Nemaline myopathy 9 Uncertain significance (Jan 27, 2022)2090506
2-169509856-C-G Nemaline myopathy 9 Likely benign (Jul 30, 2022)1919296
2-169509861-ATGAGAAAAAATTCATCGATTGCAC-TGTCA Likely pathogenic (Mar 06, 2020)817308
2-169509877-C-T Nemaline myopathy 9 Likely benign (Feb 04, 2022)2075292
2-169509879-A-G Nemaline myopathy 9 Uncertain significance (Sep 21, 2021)1417397
2-169509880-T-C Nemaline myopathy 9 Likely benign (Mar 18, 2022)792601
2-169509913-T-C Nemaline myopathy 9 Likely benign (Aug 01, 2022)1929913
2-169509923-T-C Nemaline myopathy 9 Likely benign (Dec 20, 2021)2097438
2-169509924-T-C Nemaline myopathy 9 Uncertain significance (Feb 13, 2019)859683
2-169509931-G-T Inborn genetic diseases Uncertain significance (Jun 05, 2023)2556949
2-169509931-GTCAGC-G Nemaline myopathy 9 Pathogenic (Oct 17, 2022)1982923
2-169509942-GTCCTTACT-G Nemaline myopathy 9 Pathogenic (Jun 16, 2017)581470
2-169509948-AC-CT Nemaline myopathy 9 Uncertain significance (Aug 30, 2023)934936
2-169509953-C-T Nemaline myopathy 9 Uncertain significance (Oct 03, 2023)474868

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
KLHL41protein_codingprotein_codingENST00000284669 616561
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0001110.9901257040441257480.000175
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8872823270.8620.00001723991
Missense in Polyphen84111.320.754571324
Synonymous1.171031190.8630.000006291179
Loss of Function2.271021.30.4699.84e-7299

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003070.000304
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.0001390.000139
European (Non-Finnish)0.0002470.000246
Middle Eastern0.0001630.000163
South Asian0.00009840.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in skeletal muscle development and differentiation. Regulates proliferation and differentiation of myoblasts and plays a role in myofibril assembly by promoting lateral fusion of adjacent thin fibrils into mature, wide myofibrils. Required for pseudopod elongation in transformed cells. {ECO:0000250|UniProtKB:A2AUC9}.;
Disease
DISEASE: Nemaline myopathy 9 (NEM9) [MIM:615731]: An autosomal recessive form of nemaline myopathy. Nemaline myopathies are muscular disorders characterized by muscle weakness of varying severity and onset, and abnormal thread-like or rod-shaped structures in muscle fibers on histologic examination. NEM9 phenotype is highly variable, ranging from death in infancy due to lack of antigravity movements, to slowly progressive distal muscle weakness with preserved ambulation later in childhood. {ECO:0000269|PubMed:24268659}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Post-translational protein modification;Metabolism of proteins;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation (Consensus)

Recessive Scores

pRec
0.124

Intolerance Scores

loftool
rvis_EVS
0.2
rvis_percentile_EVS
67.3

Haploinsufficiency Scores

pHI
0.875
hipred
N
hipred_score
0.455
ghis
0.517

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
gene_indispensability_score

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Klhl41
Phenotype
growth/size/body region phenotype; muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype;

Zebrafish Information Network

Gene name
klhl41a
Affected structure
skeletal muscle
Phenotype tag
abnormal
Phenotype quality
refractivity

Gene ontology

Biological process
striated muscle contraction;protein ubiquitination;myofibril assembly;regulation of lateral pseudopodium assembly;skeletal muscle cell differentiation;post-translational protein modification;sarcomere organization;regulation of myoblast differentiation;skeletal muscle fiber development;regulation of myoblast proliferation;regulation of skeletal muscle cell differentiation
Cellular component
ruffle;nucleus;cytoplasm;endoplasmic reticulum membrane;cytosol;cytoskeleton;plasma membrane;pseudopodium;M band;Cul3-RING ubiquitin ligase complex;sarcoplasmic reticulum membrane
Molecular function
protein binding